Ping Cao focuses her practice on intellectual property (IP) matters related to patent prosecution and strategies, due diligence, and transactions. Ping is a seasoned chemist who brings experience in the chemical, pharmaceutical, cosmetic, material science, polymer science, agricultural chemical, and biochemistry areas. Prior to joining Morgan Lewis, Ping served as a TC1600 patent examiner at the US Patent and Trademark Office (USPTO) for nearly six years, where she reviewed and examined patent applications in the field of pharmaceutical science (including novel chemical entities, drug formulation and delivery, new use of known drugs), cosmetics, medical implants, nanotechnology, and material sciences.
Ping has a long professional history in chemical field. After obtaining her PhD degree in organic chemistry, she embarked a career as medicinal chemist for GlaxoSmithKline (GSK) and later as lead medicinal chemist for Progenra. At GSK, Ping was a team-member of the clinical development team for a novel HIV integrase inhibitor, and also acted as matrix team leader of a lead discovery project for novel HIV therapy.
While at Progenra, Ping conducted research to develop novel small molecule inhibitors of cancer-related deubiquitylting proteases. She also served as principal investigator and prepared a Small Business Innovation Research (SBIR) grant application proposal for Progenra. As a medicinal chemist, Ping co-authored several peer-reviewed publications and was named inventor in several patent and patent applications.
Temple University, Beasley School of Law, 2018, J.D.
Pennsylvania State University, Ph.D.
Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, M.Sc., Organic Chemistry
Beijing Normal University, B.Sc., Chemistry
US Patent and Trademark Office
Awards and Affiliations
Member, Practice Group of the Year, Intellectual Property, Law360 (2019)
Member, Litigation Department of the Year–Intellectual Property, The American Lawyer (2019)